AbbVie beats earnings expectations and raises outlook, boosts dividend by 10% – MarketWatch
AbbVie Inc.
ABBV, +2.36%
reported Friday a third-quarter adjusted profit and revenue that rose above expectations, helped by strength in its immunology and oncology business segments, and raised its earnings outlook. The stock slipped 0.4% in premarket tra…
